Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wellcome unveils details of £200M fund

This article was originally published in Scrip

Executive Summary

Trailed initially last Spring (ScripIntelligence, 20 March 2012), The Wellcome Trust has revealed more details of its new £200 million fund which is being launched as Syncona Partners LLP. A return-driven evergreen investment company, Syncona intends to support the creation of sustainable healthcare businesses, focusing on therapeutics, diagnostics or medical devices, investing between £1 million to £20 million, both as a majority investor or as part of a syndicate.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts